Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cardiff Oncology, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 117 | 1 | 116 | 0 |
| Shares | 28.1M | 586.6K | 32.3M | +4.84M (+17.6%) |
| Value | $121.9M | $2.55M | $101.6M | −$17.8M (−14.9%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 857,570 | $2.69M | 0.00% |
| DAFNA Capital Management LLC | 150,000 | $471.0K | 0.13% |
| Squarepoint Ops LLC | 127,965 | $401.8K | 0.00% |
| Dauntless Investment Group, LLC | 96,208 | $302.1K | 1.12% |
| Yarbrough Capital, LLC | 88,163 | $276.8K | 0.01% |
| Steel Peak Wealth Management LLC | 18,500 | $58.1K | 0.00% |
| Brighton Jones LLC | 16,500 | $51.8K | 0.00% |
| Castleview Partners, LLC | 14,465 | $45.4K | 0.03% |
| CIBC World Markets Corp | 12,934 | $40.6K | 0.00% |
| Belpointe Asset Management LLC | 11,640 | $36.5K | 0.00% |
| Ledgewood Wealth Advisors, LLC | 11,190 | $35.1K | 0.02% |
| CoreCap Advisors, LLC | 8,000 | $25.1K | 0.00% |
| Signaturefd, LLC | 3,607 | $11.3K | 0.00% |
| Parallel Advisors, LLC | 1,000 | $3.14K | 0.00% |
| NBC Securities, Inc. | 1,000 | $3.00K | 0.00% |
| True Wealth Design, LLC | 14 | $44 | 0.00% |
| EverSource Wealth Advisors, LLC | 2 | $6 | 0.00% |
Sold out (17)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Point72 Asset Management, L.P. | 508,438 | $2.21M |
| Renaissance Technologies LLC | 483,090 | $2.10M |
| Ikarian Capital, LLC | 450,000 | $1.95M |
| Boothbay Fund Management, LLC | 129,960 | $564.0K |
| AWM Investment Company, Inc. | 106,435 | $461.9K |
| American Century Companies Inc | 53,955 | $234.2K |
| J. Goldman & Co LP | 47,250 | $205.1K |
| XTX Topco Ltd | 40,763 | $176.9K |
| Wolverine Trading, LLC | 24,482 | $104.3K |
| DRW Securities, LLC | 23,474 | $101.9K |
| Jane Street Group, LLC | 21,608 | $93.8K |
| Shay Capital LLC | 20,862 | $90.5K |
| Parr McKnight Wealth Management Group, LLC | 16,000 | $69.4K |
| The PNC Financial Services Group, Inc. | 1,520 | $6.60K |
| Fourth Dimension Wealth, LLC | 500 | $2.17K |
| Eagle Bay Advisors LLC | 339 | $1.47K |
| R Squared Ltd | 290 | $1.26K |
Not filed for Q1 2025 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 586,616 | $2.55M |